HIV Transmission Chains Exhibit Greater HLA-B Homogeneity Than Randomly Expected

被引:0
|
作者
Huyen Nguyen [1 ,2 ]
Thorball, Christian W. [3 ,4 ]
Fellay, Jacques [3 ,4 ]
Boni, Jurg [2 ]
Yerly, Sabine [5 ]
Perreau, Matthieu [6 ]
Klimkait, Thomas [7 ]
Kusejko, Katharina [1 ,2 ]
Bachmann, Nadine [1 ,2 ]
Chaudron, Sandra E. [1 ,2 ]
Paioni, Paolo [8 ]
Thurnheer, Maria C. [9 ]
Battegay, Manuel [10 ]
Cavassini, Matthias [11 ]
Vernazza, Pietro [12 ]
Bernasconi, Enos [13 ]
Gunthard, Huldrych F. [1 ,2 ]
Kouyos, Roger [1 ,2 ]
Anagnostopoulos, A.
Braun, D. L.
Bucher, H. C.
Calmy, A.
Ciuffi, A.
Dollenmaier, G.
Egger, M.
Elzi, L.
Fehr, J.
Furrer, H.
Fux, C. A.
Haerry, D.
Hasse, B.
Hirsch, H. H.
Hoffmann, M.
Hosli, I.
Huber, M.
Kahlert, C.
Kaiser, L.
Keiser, O.
Kouyos, R. D.
Kovari, H.
Ledergerber, B.
Martinetti, G.
de Tejada, B. Martinez
Marzolini, C.
Metzner, K. J.
Mueller, N.
Nicca, D.
Pantaleo, G.
Rauch, A.
Rudin, C.
机构
[1] Univ Zurich, Univ Hosp Zurich, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland
[2] Univ Zurich, Swiss Natl Ctr Retroviruses, Inst Med Virol, Zurich, Switzerland
[3] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland
[4] Swiss Inst Bioinformat, Lausanne, Switzerland
[5] Univ Geneva, Geneva Univ Hosp, Lab Virol, Geneva, Switzerland
[6] Univ Lausanne, Univ Hosp Lausanne, Div Immunol & Allergy, Lausanne, Switzerland
[7] Univ Basel, Dept Biomed, Basel, Switzerland
[8] Univ Childrens Hosp Zurich, Childrens Res Ctr, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland
[9] Univ Bern, Univ Hosp Bern, Univ Clin Infect Dis, Bern, Switzerland
[10] Univ Basel, Univ Hosp Bern, Dept Med, Infect Dis & Infect Control Clin, Basel, Switzerland
[11] Univ Lausanne, CHU Vaudois, Dept Infect Dis, Lausanne, Switzerland
[12] Kantonsspital St Gallen, Div Infect Dis & Hosp Epidemiol, St Gallen, Switzerland
[13] Reg Hosp, Div Infect Dis, Lugano, Switzerland
基金
瑞士国家科学基金会;
关键词
HLA; coevolution; transmission chains; T-CELL RESPONSES; CLASS-I; ESCAPE MUTATIONS; IMMUNE CONTROL; MATE CHOICE; EVOLUTION; DETERMINANTS; RESTRICTION; ASSOCIATION; CONCORDANCE;
D O I
10.1097/QAI.0000000000002077
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: HIV's capacity to escape immune recognition by human leukocyte antigen (HLA) is a core component of HIV pathogenesis. A better understanding of the distribution of HLA class I in HIV-infected patients would improve our knowledge of pathogenesis in relation to the host HLA type and could better improve therapeutic strategies against HIV. Materials and Methods: Three hundred one to 325 transmission pairs and 469-496 clusters were identified for analysis among Swiss HIV Cohort Study (SHCS) participants using HIV pol sequences from the drug resistance database. HLA class I data were compiled at 3 specificity levels: 4-digit, 2-digit alleles, and HLA-B supertype. The analysis tabulated HLA-I homogeneity as 2 measures: the proportion of transmission pairs, which are HLA concordant, and the average percentage of allele matches within all clusters. These measures were compared with the mean value across randomizations with randomly assorted individuals. Results: We repeated the analysis for different HLA classification levels and separately for HLA-A,-B, and-C. Subanalyses by the risk group were performed for HLA-B. HLA-B showed significantly greater homogeneity in the transmission chains (2-digit clusters: 0.291 vs. 0.251, P value = 0.009; supertype clusters: 0.659 vs. 0.611, P value = 0.002; supertype pairs: 0.655 vs. 0.608, P value = 0.014). Risk group restriction caused the effect to disappear for men-who-have-sexwith- men but not for other risk groups. We also examined if protective HLA alleles B27 and B57 were under-or overrepresented in the transmission chains, although this yielded no significant pattern. Conclusions: The HLA-B alleles of patients within HIV-1 transmission chains segregate in homogenous clusters/pairs, potentially indicating preferential transmission among HLA-B concordant individuals.
引用
收藏
页码:508 / 515
页数:8
相关论文
共 50 条
  • [41] Prevalence of HLA-B*57:01 allele in HIV-positive and HIV-negative population of eastern India: An epidemiological study
    Gautam, Abhilasha
    Chakravarty, Jaya
    Chourasia, Ankita
    Sharma, Saurabh
    Sarkar, Tanmoy
    Das, Parimal
    CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2022, 18
  • [42] Many but small HIV-1 non-B transmission chains in the Netherlands
    Bezemer, Daniela
    Blenkinsop, Alexandra
    Hall, Matthew
    van Sighem, Ard
    Cornelissen, Marion
    Wessels, Els
    van Kampen, Jeroen
    van de Laar, Thijs
    Reiss, Peter
    Fraser, Christophe
    Ratmann, Oliver
    AIDS, 2022, 36 (01) : 83 - 94
  • [43] Both HLA-B*57 and Plasma HIV RNA Levels Contribute to the HIV- Specific CD8+ T Cell Response in HIV Controllers
    Lecuroux, Camille
    Saez-Cirion, Asier
    Girault, Isabelle
    Versmisse, Pierre
    Boufassa, Faroudy
    Avettand-Fenoel, Veronique
    Rouzioux, Christine
    Meyer, Laurence
    Pancino, Gianfranco
    Lambotte, Olivier
    Sinet, Martine
    Venet, Alain
    JOURNAL OF VIROLOGY, 2014, 88 (01) : 176 - 187
  • [44] HLA-B*57:01 allele prevalence in treatment-Naive HIV-infected patients from Colombia
    Martinez Buitrago, Ernesto
    Millan Onate, Jose
    Fernando Garcia-Goez, Jose
    Alvarez, Jorge
    Lenis, William
    Marina Sanudo, Luz
    Consuelo Rubiano, Luisa
    BMC INFECTIOUS DISEASES, 2019, 19 (01)
  • [45] Subdominant Gag-specific anti-HIV efficacy in an HLA-B*57-positive elite controller
    Leitman, Ellen M.
    Willberg, Christian B.
    De Burgh-Thomas, Andrew
    Streeck, Hendrik
    Goulder, Philip J. R.
    Matthews, Philippa C.
    AIDS, 2016, 30 (06) : 972 - 974
  • [46] Polymorphic residues in HLA-B that mediate HIV control distinctly modulate peptide interactions with both TCR and KIR molecules
    Tano-Menka, Rhoda
    Singh, Nishant K.
    Muzhingi, Itai
    Li, Xiaolong
    Mandanas, Michael V.
    Kaseke, Clarety
    Crain, Charles R.
    Zhang, Angela
    Ogunshola, Funsho J.
    Vecchiarello, Liza
    Piechocka-Trocha, Alicja
    Bashirova, Arman
    Birnbaum, Michael E.
    Carrington, Mary
    Walker, Bruce D.
    Gaiha, Gaurav D.
    STRUCTURE, 2024, 32 (08) : 1121 - 1136.e5
  • [47] TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patients
    Dold, L.
    Zimmer, L.
    Schwarze-Zander, C.
    Boesecke, C.
    Mohr, R.
    Wasmuth, J. -C.
    Ommer, K.
    Gathof, B.
    Kraemer, B.
    Nattermann, J.
    Strassburg, C. P.
    Rockstroh, J. K.
    Spengler, U.
    Langhans, B.
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2021, 99 (01): : 147 - 158
  • [48] HLA-B*35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses
    Huang, Jinghe
    Goedert, James J.
    Sundberg, Eric J.
    Cung, Thai Duong Hong
    Burke, Patrick S.
    Martin, Maureen P.
    Preiss, Liliana
    Lifson, Jeffrey
    Lichterfeld, Mathias
    Carrington, Mary
    Yu, Xu G.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (13) : 2959 - 2966
  • [49] HLA-B*46 associates with rapid HIV disease progression in Asian cohorts and prominent differences in NK cell phenotype
    Li, Shuying S.
    Hickey, Andrew
    Shangguan, Shida
    Ehrenberg, Philip K.
    Geretz, Aviva
    Butler, Lauryn
    Kundu, Gautam
    Apps, Richard
    Creegan, Matthew
    Clifford, Robert J.
    Pinyakorn, Suteeraporn
    Eller, Leigh Anne
    Luechai, Pikunchai
    Gilbert, Peter B.
    Holtz, Timothy H.
    Chitwarakorn, Anupong
    Sacdalan, Carlo
    Kroon, Eugene
    Phanuphak, Nittaya
    de Souza, Mark
    Ananworanich, Jintanat
    O'Connell, Robert J.
    Robb, Merlin L.
    Michael, Nelson L.
    Vasan, Sandhya
    Thomas, Rasmi
    CELL HOST & MICROBE, 2022, 30 (08) : 1173 - +
  • [50] Cost-effectiveness analysis of HLA-B*5701 typing in the prevention of hypersensitivity to abacavir in HIV plus patients in Spain
    Nieves Calatrava, Diana
    de la Calle-Martin, Oscar
    Iribarren-Loyarte, Jose A.
    Rivero-Roman, Antonio
    Garcia-Bujalance, Laura
    Perez-Escolano, Isabel
    Brosa-Riestra, Max
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2010, 28 (09): : 590 - 595